davek
Player Valuation: £150m
I'm saying that in normal times it would never have been licensed. Theyld have had the time to pick this side effect up and then dealt with it.Why exactly has it been a disaster? Because of a few minor cases of clotting? When Pfizer and now J&J have reported the same, should they be binned off too?
There's no point in denying that. I pick on AZ because in terms of incidences this is the one that has been the problem with rare cerebral thrombosis.

